Clinical Trial Update: CTLA-4 Blockade and Low Dose Cyclophosphamide in Patients With Advanced Malignant Melanoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating CTLA-4 blockade in combination with low-dose cyclophosphamide for advanced melanoma has been terminated. Results from the study have be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• ipilimumab (ipilimumab)

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Melanoma | Phase 2 | Status: TERMINATED | Results posted: 2017-04-26